initiated by the stimulation of naive T lymphocytes by dendritic cells in the secondary lymphoid organs, such as the spleen and lymph nodes. Dendritic cells are distributed throughout the body, particularly at the skin and the mucosal surfaces where pathogens are most frequently encountered. Upon capturing antigens, the dendritic cells in peripheral tissue migrate into the local lymph node through the afferent lymphatic vessels and present antigens to naive lymphocytes. In addition to these migrating dendritic cells, certain subsets of dendritic cells reside strictly in the secondary lymphoid organs and are collectively known as blood-derived dendritic cells. These dendritic cells arrive as precursors from the blood and differentiate into various subsets in situ. − dendritic cells (Figure 1 ). By making chimeric molecules of anti-DEC205 antibody fused to a model antigen, the authors showed that antigen is taken up by the CD8 + dendritic cells in vivo, which subsequently resulted in preferential stimulation of antigen-specific CD8 T cells. In contrast, injection of 33D1 antibody-antigen chimeric protein resulted in targeting of antigen to the CD8 − dendritic cells and subsequent stimulation of cognate CD4 T cells. Although both types of chimeric antibody-antigen proteins resulted in stimulation of both T cell subsets at high doses, a ten-fold difference in the efficiency of presentation was detected.
Such preferential association of these dendritic cell subsets in priming of CD4 and CD8 T cells is consistent with previous studies that have examined the ability of ex vivo isolated dendritic cell subsets to stimulate T cell responses following in vivo injection of protein antigens (Itano et al., 2003) , cells (den Haan et al., 2000) , or viruses (Allan et al., 2003; Zhao et al., 2003) . Specifically, CD8
+ blood-derived dendritic cells are well known for their ability to present exogenous antigens on MHC class I molecules (Heath et al., 2004) , in a process known as crosspriming. It was unclear whether the ability of CD8 + dendritic cells in crosspriming was due to their ability to capture the antigen or to process and present the antigen on MHC class I. By isolating splenic dendritic cells that have captured equal number of antigencoated beads following systemic administration of labeled beads into mice, crosspresentation was shown to be much more efficient in CD8 + dendritic cells compared to CD8 − dendritic cells (Schnorrer et al., 2006 Dendritic cells induce the activation of CD8 and CD4 T cells by presenting antigenic peptides on MHC class I and class II molecules, respectively. In a recent Science paper, Dudziak et al. (2007) reveal that these tasks are handled by distinct populations of dendritic cells in vivo.
division of labor by dendritic cell subsets to present soluble protein antigen injected systemically, do such rules apply also to infectious agents? Most infections begin at mucosal surfaces, and rapid and efficient induction of antimicrobial adaptive immunity is crucial for the survival of the host. Given that the dendritic cells in the lymph nodes have not been reported to express DCIR2 (Witmer and Steinman, 1984) , it would be interesting to test whether the DCIR2 − CD8 − dendritic cells in the lymph nodes possess similar affinity toward presentation of antigen on class II MHC. In a similar vein, CD8 + and CD8 − dendritic cells express different subsets of Toll-like receptors and presumably other pattern recognition receptors. It would be important to investigate how this relates to their differential ability to activate CD4 and CD8 T cells, particularly in response to infection or vaccination. Finally, because dendritic cells that migrate from tissues transport peripheral antigen to the lymph nodes (Allan et al., 2006) , the relative contributions of these dendritic cells and the blood-derived ones (CD8 + and CD8 − subsets) in priming CD4 T cells following local infection will need to be determined. Surely, the study by Dudziak and colleagues (2007) provides an important catalyst for future investigations to address these and other pertinent questions. (Left) CD8 + dendritic cells express high levels of molecules required for crosspresentation on MHC class I. These include the TAP1-TAP2 complex, which transports small peptides into the class I loading compartment; the endoplasmic reticulum-associated degradation (ERAD) export system, which allows translocation of intravesicular protein to the cytosol; ERAAP, aminopeptidase associated with antigen processing; and ERp57, Tapasin (Tpsn), calreticulin (CRT), calnexin (CNX), which are all required for assembly of MHC class I heavy chain + β2m + peptide complex. The class I loading may occur in the ER or ER-phagosome-like compartments. (Right) CD8
− dendritic cells preferentially express molecules required for MHC class II processing and presentation. These include cathepsin family members, capable of fragmenting endocytosed proteins to provide ligands for MHC class II; γ-IFN-inducible lysosomal thiol reductase (GILT), which reduces proteins within the MHC class II loading compartment allowing exposure of residues for class II binding and protease trimming; and HLA-DM, which catalyzes the exchange between class II-associated invariant chain peptide (CLIP) and antigenic peptides onto MHC class II molecules. These figures are based on Cresswell et al. (2005) .
